Unknown OBSERVATIONAL NCT06144866

Evaluataion of NOAC Levels in Acute Stroke

Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants Concentration Among Patients With Acute Stroke (The Direct Oral AntiCoagulant Registry in Taiwan-Emergent Department, DOACT-ED)

Sponsor: National Taiwan University Hospital

Conditions Anticoagulant Adverse Reaction Ischemic Stroke

Interventions Dabigatran, rivaroxaban, apixaban, edoxaban

Updated 4 times since 2023 Last updated: Nov 22, 2023 Started: May 1, 2020 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06144866, this observational or N/A phase trial focuses on Anticoagulant Adverse Reaction and Ischemic Stroke and remains ongoing. Sponsored by National Taiwan University Hospital, it has been updated 4 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Dec 2023 — Jul 2024 [monthly]

Recruiting

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan